Detailed information for compound 561797

Basic information

Technical information
  • TDR Targets ID: 561797
  • Name: aniline; phosphoric acid
  • MW: 191.122 | Formula: C6H10NO4P
  • H donors: 4 H acceptors: 4 LogP: -0.85 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: OP(=O)(O)O.Nc1ccccc1
  • InChi: 1S/C6H7N.H3O4P/c7-6-4-2-1-3-5-6;1-5(2,3)4/h1-5H,7H2;(H3,1,2,3,4)
  • InChiKey: JAZCSWFKVAHBLR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • phenylamine; phosphoric acid
  • 37832-42-1
  • Anilinium dihydrogen phosphate
  • Benzenamine phosphate (1:1)
  • Benzenamine, phosphate (1:1)
  • EINECS 253-680-8

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major delta tubulin, putative Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major epsilon tubulin, putative Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major gamma-tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major zeta tubulin, putative Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein Get druggable targets OG5_130726 All targets in OG5_130726
Loa Loa (eye worm) tubulin beta-4 chain Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium yoelii tubulin beta chain Get druggable targets OG5_130726 All targets in OG5_130726
Schistosoma japonicum Tubulin beta-7 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Brugia malayi Tubulin beta-1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin, putative Get druggable targets OG5_127652 All targets in OG5_127652
Cryptosporidium parvum gamma tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii beta-tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania infantum beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha 2 Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) BEN-1 protein Get druggable targets OG5_126611 All targets in OG5_126611
Theileria parva Tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Neospora caninum tubulin delta chain, putative Get druggable targets OG5_143817 All targets in OG5_143817
Loa Loa (eye worm) alpha-tubulin isotype 2 Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium yoelii Tubulin/FtsZ family, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Plasmodium knowlesi alpha tubulin, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Theileria parva tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania donovani tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma brucei gambiense delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Loa Loa (eye worm) tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Babesia bovis tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K07375 tubulin beta, putative Get druggable targets OG5_126611 All targets in OG5_126611
Candida albicans gamma tubulin-like protein Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei zeta tubulin Get druggable targets OG5_145938 All targets in OG5_145938
Echinococcus multilocularis hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin beta-1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma cruzi epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Neospora caninum tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Babesia bovis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Toxoplasma gondii beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K10391 tubulin epsilon, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Cryptosporidium parvum alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Leishmania braziliensis alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Theileria parva tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania infantum delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Trypanosoma cruzi zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania donovani zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Trypanosoma cruzi beta tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma congolense tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma congolense zeta tubulin Get druggable targets OG5_145938 All targets in OG5_145938
Neospora caninum hypothetical protein Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma congolense beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium vivax tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei gambiense alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii alpha-tubulin I, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Theileria parva tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin epsilon chain Get druggable targets OG5_130726 All targets in OG5_130726
Brugia malayi tubulin alpha chain - mouse Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Candida albicans gamma tubulin-like protein Get druggable targets OG5_127652 All targets in OG5_127652
Brugia malayi Tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Entamoeba histolytica tubulin family protein Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium berghei tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus multilocularis tubulin gamma 1 chain Get druggable targets OG5_127652 All targets in OG5_127652
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin beta 4A class IVa Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K07375 tubulin beta, putative Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Gamma tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Schistosoma japonicum Tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium berghei alpha tubulin 2 Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta-1 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania mexicana Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin beta-2A chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania infantum epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trichomonas vaginalis tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium falciparum alpha tubulin 1 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin beta 1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium falciparum tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania donovani alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma cruzi zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania infantum gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Brugia malayi Tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Trypanosoma cruzi tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Trypanosoma congolense alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni tubulin subunit alpha Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin subunit TubB Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin alpha-2/alpha-4 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Neospora caninum tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Giardia lamblia Beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha 2 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha 2 Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium vivax tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trichomonas vaginalis tubulin gamma chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium falciparum tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii alpha tubulin TUBA1 Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania major delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Loa Loa (eye worm) alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Candida albicans cytoskeletal structural protein Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma cruzi alpha tubulin, putative Get druggable targets OG5_126605 All targets in OG5_126605
Entamoeba histolytica tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania braziliensis beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Neospora caninum hypothetical protein Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Babesia bovis tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Brugia malayi tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) BEN-1 protein Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta-4 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium vivax tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus multilocularis beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium falciparum tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium yoelii tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma cruzi tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium knowlesi alpha-tubulin II, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis peroxisome assembly protein 26 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit alpha Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Brugia malayi Tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Plasmodium yoelii tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus multilocularis tubulin epsilon chain Get druggable targets OG5_130726 All targets in OG5_130726
Plasmodium falciparum alpha tubulin 2 Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum Tubulin alpha-1C chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein Get druggable targets OG5_143817 All targets in OG5_143817
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii beta-1 tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei gambiense gamma tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Loa Loa (eye worm) tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Cryptosporidium hominis gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus multilocularis tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Entamoeba histolytica tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei gambiense beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania donovani epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus granulosus Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania mexicana gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus granulosus tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma cruzi tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Neospora caninum hypothetical protein Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K07374 tubulin alpha, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Cryptosporidium parvum tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Cryptosporidium hominis alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin, beta 4A class IVa Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania infantum beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Brugia malayi beta-tubulin, identical Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum Tubulin beta-1 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit alpha Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus peroxisome assembly protein 26 Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania donovani tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Schistosoma mansoni tubulin subunit gamma Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Neospora caninum Beta-tubulin, related Get druggable targets OG5_127652 All targets in OG5_127652
Entamoeba histolytica tubulin family protein Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium berghei tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Plasmodium knowlesi tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trichomonas vaginalis tubulin gamma chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Plasmodium vivax tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Entamoeba histolytica tubulin alpha-1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei gambiense epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K10389 tubulin gamma, putative Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma brucei gambiense beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin gamma 1 chain Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma congolense tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Brugia malayi alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium vivax tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Cryptosporidium hominis beta-catenin-like repeat protein Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin subunit TubB Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit epsilon Get druggable targets OG5_130726 All targets in OG5_130726
Trypanosoma brucei zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania major zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania infantum beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K07374 tubulin alpha, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin beta 1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha-3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Babesia bovis tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei gambiense zeta tubulin Get druggable targets OG5_145938 All targets in OG5_145938
Plasmodium knowlesi tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Brugia malayi Tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma congolense epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin alpha chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma cruzi epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium yoelii tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania braziliensis gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium berghei tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium berghei alpha tubulin 1 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Trypanosoma brucei epsilon tubulin epsilon tubulin, putative 470 aa 488 aa 68.0 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin epsilon chain, putative gamma-tubulin 447 aa 479 aa 28.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis L aminoadipate semialdehyde 0.0081 0.0425 0.0425
Schistosoma mansoni chromobox protein 0.0068 0.034 0.0396
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0016 0.001 0.001
Loa Loa (eye worm) heterochromatin protein 1 0.0068 0.034 0.0602
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Brugia malayi chromobox protein homolog 3 0.0038 0.0152 0.0392
Echinococcus granulosus Tubulin alpha 1 chain 0.0471 0.2896 0.3371
Wolbachia endosymbiont of Brugia malayi cell division protein FtsZ 0.0161 0.0933 1
Leishmania major epsilon tubulin, putative 0.0384 0.2343 0.6042
Echinococcus granulosus histone acetyltransferase MYST2 0.0053 0.0245 0.0286
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0046 0.0205 0.0506
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0056 0.0269 0.0665
Plasmodium falciparum tubulin epsilon chain, putative 0.0384 0.2343 0.6039
Loa Loa (eye worm) hypothetical protein 0.031 0.1874 0.3318
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Trichomonas vaginalis tubulin epsilon chain, putative 0.0471 0.2896 0.7481
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0677 0.4205 1
Schistosoma mansoni microtubule-associated protein tau 0.1369 0.8591 1
Brugia malayi CXXC zinc finger family protein 0.0028 0.0092 0.0237
Schistosoma mansoni photoreceptor-specific nuclear receptor related 0.002 0.0038 0.0045
Schistosoma mansoni smad1 5 8 and 0.0017 0.0017 0.002
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0056 0.0269 0.0665
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Trypanosoma cruzi tubulin delta chain 0.0363 0.221 0.5699
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0096 0.0518 0.0518
Brugia malayi beta-tubulin, identical 0.0625 0.3871 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.0179
Schistosoma mansoni cpg binding protein 0.0028 0.0092 0.0107
Echinococcus granulosus tubulin delta chain 0.0161 0.0933 0.1086
Echinococcus granulosus tubulin beta 1 chain 0.0625 0.3871 0.4506
Trichomonas vaginalis PIKK family atypical protein kinase 0.0046 0.0205 0.0529
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Trichomonas vaginalis conserved hypothetical protein 0.0027 0.0081 0.0209
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Loa Loa (eye worm) MH1 domain-containing protein 0.0017 0.0017 0.003
Schistosoma mansoni FTZ-F1 nuclear receptor-like protein 0.002 0.0038 0.0045
Echinococcus multilocularis tubulin, beta 4A class IVa 0.0625 0.3871 0.3871
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0046 0.0205 0.053
Loa Loa (eye worm) flap endonuclease-1 0.0028 0.0086 0.0152
Schistosoma mansoni tubulin subunit beta 0.0161 0.0933 0.1086
Echinococcus granulosus geminin 0.0178 0.1038 0.1208
Echinococcus multilocularis TGF beta signal transducer SmadC 0.0017 0.0017 0.0017
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Echinococcus granulosus tar DNA binding protein 0.0062 0.0301 0.0351
Trypanosoma cruzi epsilon tubulin, putative 0.0384 0.2343 0.6042
Plasmodium falciparum tubulin beta chain 0.0625 0.3871 1
Entamoeba histolytica Niemann-Pick C1 protein, putative 0.0098 0.053 0.134
Trypanosoma cruzi PAB1-binding protein , putative 0.0053 0.0248 0.0617
Loa Loa (eye worm) hypothetical protein 0.0207 0.1222 0.2162
Schistosoma mansoni smad 0.0017 0.0017 0.002
Trichomonas vaginalis ap endonuclease, putative 0.0056 0.0269 0.0695
Brugia malayi mbt repeat family protein 0.0046 0.0205 0.0529
Brugia malayi MH1 domain containing protein 0.0017 0.0017 0.0044
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.0056 0.0269 0.0672
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.0179
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Echinococcus multilocularis neuropeptide s receptor 0.047 0.2892 0.2892
Plasmodium vivax tubulin beta chain, putative 0.0625 0.3871 1
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Schistosoma mansoni alpha tubulin 0.0471 0.2896 0.3371
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0087 0.0223
Echinococcus multilocularis Niemann Pick C1 protein 0.014 0.0796 0.0796
Loa Loa (eye worm) nuclear hormone receptor family member nhr-1 0.002 0.0038 0.0068
Schistosoma mansoni smad1 5 8 and 0.0017 0.0017 0.002
Mycobacterium leprae possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). 0.0034 0.0128 0.0822
Trypanosoma cruzi target of rapamycin kinase 3 0.0037 0.0145 0.0351
Echinococcus multilocularis endonuclease exonuclease phosphatase 0.0194 0.1141 0.1141
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0302 0.1828 0.3236
Toxoplasma gondii flap structure-specific endonuclease 1, putative 0.0028 0.0086 0.0189
Brugia malayi MH1 domain containing protein 0.0017 0.0017 0.0044
Mycobacterium tuberculosis Probable esterase LipL 0.0106 0.0583 0.1272
Loa Loa (eye worm) hypothetical protein 0.0098 0.053 0.0938
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Schistosoma mansoni nuclear receptor 2DBD-gamma 0.002 0.0038 0.0045
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Toxoplasma gondii HEAT repeat-containing protein 0.0085 0.0449 0.113
Mycobacterium ulcerans beta-lactamase 0.0106 0.0583 0.6016
Echinococcus multilocularis hypothetical protein 0.0471 0.2896 0.2896
Giardia lamblia Alpha-tubulin 0.0471 0.2896 0.7424
Brugia malayi Pre-SET motif family protein 0.0032 0.0114 0.0294
Echinococcus multilocularis Niemann Pick C1 protein 0.0098 0.053 0.053
Trichomonas vaginalis tubulin gamma chain, putative 0.0384 0.2346 0.606
Schistosoma mansoni hypothetical protein 0.0178 0.1038 0.1208
Schistosoma mansoni cpg binding protein 0.003 0.0102 0.0119
Leishmania major beta tubulin 0.0625 0.3871 1
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.0056 0.0269 0.0672
Trichomonas vaginalis ran, putative 0.0062 0.0307 0.0792
Trichomonas vaginalis conserved hypothetical protein 0.0042 0.0177 0.0456
Schistosoma mansoni hypothetical protein 0.0024 0.0062 0.0072
Mycobacterium tuberculosis Conserved protein 0.0106 0.0583 0.1272
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0092 0.0493 0.0493
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Loa Loa (eye worm) nuclear hormone receptor family member nhr-14 0.002 0.0038 0.0068
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Echinococcus multilocularis nuclear receptor 2DBD gamma 0.002 0.0038 0.0038
Echinococcus multilocularis tubulin subunit beta 0.0625 0.3871 0.3871
Trypanosoma cruzi hypothetical protein, conserved 0.0106 0.0583 0.1485
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Onchocerca volvulus Heterochromatin protein 1 homolog 0.0038 0.0152 0.1017
Brugia malayi Nuclear hormone receptor family member nhr-19 0.002 0.0038 0.0099
Loa Loa (eye worm) alpha-tubulin 0.0471 0.2896 0.5126
Brugia malayi Tubulin alpha chain 0.0471 0.2896 0.7481
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Loa Loa (eye worm) hypothetical protein 0.0053 0.0248 0.0439
Toxoplasma gondii alpha tubulin TUBA1 0.0471 0.2896 0.7473
Plasmodium falciparum tubulin delta chain, putative 0.0161 0.0933 0.2384
Loa Loa (eye worm) hypothetical protein 0.0046 0.0205 0.0363
Trichomonas vaginalis tubulin epsilon chain, putative 0.0625 0.3871 1
Leishmania major phosphopantetheinyl transferase-like protein 0.0023 0.0056 0.0119
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0271 0.163 0.2885
Echinococcus granulosus FTZ F1 nuclear receptor protein 0.002 0.0038 0.0045
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Trichomonas vaginalis tubulin beta-1 chain, putative 0.0161 0.0933 0.2409
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0092 0.0493 0.0573
Plasmodium falciparum tubulin gamma chain 0.0384 0.2346 0.6047
Brugia malayi Nuclear hormone receptor family member nhr-40 0.002 0.0038 0.0099
Onchocerca volvulus 0.0101 0.0554 0.3715
Brugia malayi RNA binding protein 0.0062 0.0301 0.0778
Brugia malayi TAR-binding protein 0.0062 0.0301 0.0778
Trypanosoma cruzi alpha tubulin, putative 0.0471 0.2896 0.7475
Trichomonas vaginalis myo inositol monophosphatase, putative 0.0038 0.0153 0.0395
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Brugia malayi CHE-14 protein 0.0042 0.0177 0.0457
Echinococcus granulosus Niemann Pick C1 protein 0.014 0.0796 0.0926
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0062 0.0301 0.0351
Echinococcus granulosus microtubule associated protein 2 0.1369 0.8591 1
Brugia malayi Nuclear hormone receptor family member nhr-19 0.002 0.0038 0.0099
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.0471 0.2896 0.7481
Brugia malayi serine/threonine-protein kinase plk-2 0.0092 0.0493 0.1273
Trypanosoma brucei hypothetical protein, conserved 0.0106 0.0583 0.1485
Trypanosoma cruzi myo-inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Echinococcus multilocularis GPCR, family 2 0.0096 0.0518 0.0518
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Brugia malayi Cell division protein ftsZ 0.0161 0.0933 0.2409
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Loa Loa (eye worm) phosphatidylinositol 3 0.0016 0.001 0.0017
Onchocerca volvulus 0.0046 0.0205 0.1374
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0106 0.0583 0.1032
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0271 0.163 0.1897
Echinococcus multilocularis tubulin alpha 3 chain 0.0471 0.2896 0.2896
Echinococcus granulosus importin subunit beta 1 0.0085 0.0449 0.0522
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog 0.002 0.0038 0.0257
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Schistosoma mansoni smad1 5 8 and 0.0017 0.0017 0.002
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Toxoplasma gondii beta-tubulin, putative 0.0625 0.3871 1
Echinococcus multilocularis tubulin gamma 1 chain 0.0384 0.2346 0.2346
Echinococcus multilocularis polycomb protein SCMH1 0.0046 0.0205 0.0205
Leishmania major beta tubulin 0.0625 0.3871 1
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Brugia malayi mbt repeat family protein 0.0046 0.0205 0.0529
Brugia malayi kap beta 3 protein 0.0016 0.0013 0.0033
Brugia malayi Tubulin alpha-2 chain 0.0471 0.2896 0.7481
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0271 0.163 0.163
Trichomonas vaginalis PIKK family atypical protein kinase 0.0046 0.0205 0.0529
Onchocerca volvulus Huntingtin homolog 0.0121 0.0681 0.4571
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Mycobacterium ulcerans extragenic suppressor protein SuhB 0.0038 0.0153 0.1111
Brugia malayi Tubulin beta chain 0.019 0.1118 0.2887
Onchocerca volvulus 0.0106 0.0583 0.3913
Brugia malayi beta-lactamase family protein 0.0106 0.0583 0.1507
Trypanosoma brucei epsilon tubulin 0.0384 0.2343 0.6042
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0046 0.0205 0.0506
Schistosoma mansoni tubulin subunit epsilon 0.0384 0.2343 0.2727
Echinococcus granulosus expressed conserved protein 0.0092 0.0492 0.0573
Schistosoma mansoni RAR-like nuclear receptor 0.002 0.0038 0.0045
Trypanosoma brucei tubulin delta chain 0.0363 0.221 0.5699
Echinococcus multilocularis hepatocyte nuclear factor 4 alpha 0.002 0.0038 0.0038
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Leishmania major gamma-tubulin 0.0384 0.2346 0.605
Trichomonas vaginalis CAMK family protein kinase 0.0045 0.0199 0.0513
Echinococcus granulosus histone lysine methyltransferase setb 0.0032 0.0114 0.0132
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Echinococcus granulosus tubulin subunit TubB 0.0471 0.2896 0.3371
Loa Loa (eye worm) MH2 domain-containing protein 0.0245 0.1462 0.2588
Brugia malayi beta-lactamase 0.0106 0.0583 0.1507
Echinococcus granulosus neuropeptide receptor A26 0.047 0.2892 0.3366
Leishmania major beta tubulin 0.0625 0.3871 1
Trypanosoma cruzi tubulin delta chain 0.0363 0.221 0.5699
Echinococcus multilocularis dnaJ subfamily B 0.0406 0.2482 0.2482
Plasmodium vivax importin-beta 2, putative 0.0085 0.0449 0.113
Echinococcus granulosus GTP binding nuclear protein Ran 0.0062 0.0307 0.0357
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Brugia malayi beta-lactamase family protein 0.0106 0.0583 0.1507
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) pre-SET domain-containing protein family protein 0.0219 0.1299 0.23
Loa Loa (eye worm) CXXC zinc finger family protein 0.0028 0.0092 0.0162
Loa Loa (eye worm) MH2 domain-containing protein 0.0017 0.0017 0.003
Schistosoma mansoni cpg binding protein 0.003 0.0102 0.0119
Plasmodium falciparum flap endonuclease 1 0.0028 0.0086 0.0189
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.0032 0.0114 0.0132
Plasmodium falciparum alpha tubulin 1 0.0471 0.2896 0.7473
Trichomonas vaginalis tubulin, putative 0.0194 0.1139 0.2943
Loa Loa (eye worm) alpha-tubulin isotype 2 0.031 0.1874 0.3318
Leishmania major delta tubulin, putative 0.0363 0.221 0.5699
Brugia malayi Steroid receptor seven-up type 2 0.002 0.0038 0.0099
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.0032 0.0114 0.0132
Brugia malayi hypothetical protein 0.0053 0.0248 0.0641
Giardia lamblia Epsilon tubulin 0.0193 0.1136 0.2776
Brugia malayi tubulin alpha chain - mouse 0.0471 0.2896 0.7481
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.0281 0.169 0.4364
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Echinococcus multilocularis histone lysine methyltransferase setb histone lysine methyltransferase eggless 0.0032 0.0114 0.0114
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Entamoeba histolytica tubulin gamma chain 0.0384 0.2346 0.6047
Echinococcus multilocularis microtubule associated protein 2 0.1369 0.8591 0.8591
Echinococcus granulosus neuropeptide s receptor 0.047 0.2892 0.3366
Trypanosoma brucei importin beta-1 subunit, putative 0.0085 0.0449 0.1137
Leishmania major beta tubulin 0.0625 0.3871 1
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0016 0.001 0.0011
Trypanosoma cruzi flap endonuclease-1 (FEN-1), putative 0.0028 0.0086 0.0197
Toxoplasma gondii histone lysine methyltransferase SET/SUV39 0.0032 0.0114 0.0261
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0302 0.1828 0.4723
Trypanosoma cruzi importin beta-1 subunit, putative 0.0069 0.0347 0.0874
Leishmania major hypothetical protein, conserved 0.0016 0.0013 0.0008
Loa Loa (eye worm) abnormal chemotaxis protein 14 0.0042 0.0177 0.0313
Echinococcus multilocularis thyroid hormone receptor alpha 0.0145 0.083 0.083
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Schistosoma mansoni alpha tubulin 0.0471 0.2896 0.3371
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Plasmodium vivax GTP-binding nuclear protein RAN/TC4, putative 0.0062 0.0307 0.0762
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Schistosoma mansoni kinase 0.0047 0.0207 0.0241
Loa Loa (eye worm) tubulin alpha chain 0.0471 0.2896 0.5126
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Echinococcus multilocularis Mitotic checkpoint protein PRCC, C terminal 0.0125 0.0703 0.0703
Loa Loa (eye worm) hypothetical protein 0.0085 0.0449 0.0794
Brugia malayi Ligand-binding domain of nuclear hormone receptor family protein 0.002 0.0038 0.0099
Schistosoma mansoni cellular tumor antigen P53 0.0101 0.0554 0.0644
Schistosoma mansoni hypothetical protein 0.0125 0.0703 0.0819
Echinococcus granulosus Mitotic checkpoint protein PRCC C terminal 0.0125 0.0703 0.0819
Echinococcus granulosus SAM and MBT domain containing protein 0.0046 0.0205 0.0238
Plasmodium vivax tubulin alpha chain, putative 0.0471 0.2896 0.7473
Loa Loa (eye worm) nuclear hormone receptor family member nhr-31 0.002 0.0038 0.0068
Echinococcus multilocularis Nuclear hormone receptor family member nhr 41 0.002 0.0038 0.0038
Brugia malayi GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0793
Plasmodium vivax tubulin alpha chain, putative 0.0471 0.2896 0.7473
Brugia malayi Nuclear hormone receptor family member nhr-14 0.002 0.0038 0.0099
Trichomonas vaginalis flap endonuclease-1, putative 0.0028 0.0086 0.022
Brugia malayi RNA, U transporter 1 0.0241 0.144 0.3719
Echinococcus multilocularis flap endonuclease 1 0.0028 0.0086 0.0086
Echinococcus granulosus beta LACTamase domain containing family member 0.0106 0.0583 0.0679
Trichomonas vaginalis penicillin-binding protein, putative 0.0106 0.0583 0.1506
Echinococcus multilocularis FTZ F1 alpha 0.002 0.0038 0.0038
Onchocerca volvulus 0.0106 0.0583 0.3913
Loa Loa (eye worm) BEN-1 protein 0.0625 0.3871 0.6852
Leishmania major beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0046 0.0205 0.0506
Brugia malayi MH2 domain containing protein 0.0017 0.0017 0.0044
Loa Loa (eye worm) tubulin beta-4 chain 0.0625 0.3871 0.6852
Echinococcus multilocularis beta LACTamase domain containing family member 0.0106 0.0583 0.0583
Onchocerca volvulus 0.003 0.01 0.0669
Echinococcus multilocularis tumor protein p63 0.0692 0.4301 0.4301
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Giardia lamblia Kinase, PLK 0.0092 0.0493 0.1075
Brugia malayi photoreceptor-specific nuclear receptor 0.002 0.0038 0.0099
Echinococcus multilocularis tubulin subunit TubB 0.0471 0.2896 0.2896
Schistosoma mansoni retinoid-x-receptor (RXR) 0.002 0.0038 0.0045
Trichomonas vaginalis PIKK family atypical protein kinase 0.0031 0.0108 0.0279
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Echinococcus granulosus importin 5 0.0016 0.0013 0.0015
Echinococcus multilocularis COUP TF:Svp nuclear hormone receptor 0.002 0.0038 0.0038
Toxoplasma gondii LsmAD domain-containing protein 0.0053 0.0248 0.061
Brugia malayi Pre-SET motif family protein 0.0219 0.1299 0.3356
Echinococcus multilocularis tubulin delta chain 0.0161 0.0933 0.0933
Loa Loa (eye worm) RNA binding protein 0.0062 0.0301 0.0533
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0016 0.001 0.0025
Echinococcus granulosus endonuclease exonuclease phosphatase 0.0194 0.1141 0.1328
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Loa Loa (eye worm) tubulin alpha chain 0.0471 0.2896 0.5126
Plasmodium vivax hypothetical protein, conserved 0.0106 0.0583 0.1478
Echinococcus multilocularis geminin 0.0178 0.1038 0.1038
Trypanosoma cruzi tubulin gamma chain 0.0384 0.2346 0.605
Brugia malayi Importin beta-1 subunit 0.0085 0.0449 0.1159
Trypanosoma brucei Importin-beta N-terminal domain/HEAT-like repeat, putative 0.0016 0.0013 0.0008
Echinococcus granulosus flap endonuclease 1 0.0028 0.0086 0.01
Echinococcus multilocularis transportin 1 0.0016 0.0013 0.0013
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.007 0.0353 0.0411
Trypanosoma brucei beta tubulin 0.0351 0.2139 0.5514
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Loa Loa (eye worm) hypothetical protein 0.0281 0.169 0.2991
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Chlamydia trachomatis holo [acyl-carrier protein] synthase 0.0023 0.0056 0.5
Trypanosoma brucei zeta tubulin 0.0498 0.3068 0.7921
Echinococcus multilocularis tubulin alpha 1C chain 0.0471 0.2896 0.2896
Loa Loa (eye worm) alpha-tubulin 0.0471 0.2896 0.5126
Giardia lamblia Gamma tubulin 0.0384 0.2346 0.5971
Schistosoma mansoni coup transcription factor 0.002 0.0038 0.0045
Schistosoma mansoni hypothetical protein 0.0293 0.1768 0.2059
Echinococcus multilocularis mothers against decapentaplegic 5 0.0017 0.0017 0.0017
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.0056 0.0269 0.0672
Leishmania major hypothetical protein, conserved 0.0053 0.0248 0.0617
Echinococcus granulosus TGF beta signal transducer SmadC 0.0017 0.0017 0.002
Brugia malayi Smad1 0.0017 0.0017 0.0044
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0046 0.0205 0.0205
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0046 0.0205 0.0506
Echinococcus granulosus tubulin alpha 1C chain 0.0471 0.2896 0.3371
Brugia malayi MH2 domain containing protein 0.0245 0.1462 0.3777
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0096 0.0518 0.0603
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Echinococcus multilocularis tubulin beta 1 chain 0.0625 0.3871 0.3871
Schistosoma mansoni tubulin subunit gamma 0.0384 0.2346 0.2731
Echinococcus multilocularis suppression of tumorigenicity 18 protein 0.0053 0.0245 0.0245
Loa Loa (eye worm) hypothetical protein 0.0038 0.0152 0.0268
Entamoeba histolytica tubulin family protein 0.0625 0.3871 1
Trichomonas vaginalis conserved hypothetical protein 0.0038 0.0152 0.0391
Schistosoma mansoni myelin transcription factor 1 myt1 0.0053 0.0245 0.0286
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.0056 0.0269 0.0672
Schistosoma mansoni hypothetical protein 0.0406 0.2482 0.2889
Trichomonas vaginalis myo inositol monophosphatase, putative 0.0038 0.0153 0.0395
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0018 0.0022 0.0057
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Giardia lamblia Beta tubulin 0.0625 0.3871 1
Schistosoma mansoni importin beta-1 0.0085 0.0449 0.0522
Brugia malayi alpha-tubulin 0.0471 0.2896 0.7481
Echinococcus granulosus tubulin alpha 3 chain 0.0471 0.2896 0.3371
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Echinococcus granulosus cpg binding protein 0.003 0.0102 0.0119
Schistosoma mansoni hypothetical protein 0.0178 0.1038 0.1208
Trichomonas vaginalis tubulin, putative 0.0625 0.3871 1
Echinococcus multilocularis protein dispatched 1 0.0048 0.0214 0.0214
Schistosoma mansoni chromobox protein 0.0068 0.034 0.0396
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Loa Loa (eye worm) hypothetical protein 0.0053 0.0245 0.0434
Mycobacterium tuberculosis Probable conserved lipoprotein 0.0106 0.0583 0.1272
Trichomonas vaginalis inositol monophosphatase, putative 0.0038 0.0153 0.0395
Loa Loa (eye worm) tubulin beta-2A chain 0.0625 0.3871 0.6852
Brugia malayi Nuclear hormone receptor family member nhr-3 0.002 0.0038 0.0099
Loa Loa (eye worm) TAR-binding protein 0.0062 0.0301 0.0533
Toxoplasma gondii ABC1 family protein 0.0106 0.0583 0.1478
Onchocerca volvulus 0.0249 0.149 1
Trypanosoma brucei epsilon tubulin 0.0384 0.2343 0.6042
Loa Loa (eye worm) tubulin gamma chain 0.0384 0.2346 0.4152
Giardia lamblia Beta tubulin 0.0625 0.3871 1
Trypanosoma cruzi zeta tubulin, putative 0.0498 0.3068 0.7921
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Echinococcus multilocularis translational activator gcn1 0.0016 0.0013 0.0013
Schistosoma mansoni Smad4 0.0017 0.0017 0.002
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Schistosoma mansoni steroid hormone receptor ad4bp 0.002 0.0038 0.0045
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0271 0.163 0.421
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Onchocerca volvulus Huntingtin homolog 0.0121 0.0681 0.4571
Loa Loa (eye worm) hypothetical protein 0.0121 0.0681 0.1206
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Trypanosoma brucei epsilon tubulin 0.0351 0.2139 0.5514
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Echinococcus granulosus nuclear receptor 2DBD gamma 0.002 0.0038 0.0045
Giardia lamblia Beta tubulin 0.0625 0.3871 1
Echinococcus granulosus translational activator gcn1 0.0016 0.0013 0.0015
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0271 0.163 0.1897
Echinococcus multilocularis SAM and MBT domain containing protein 0.0046 0.0205 0.0205
Leishmania major beta tubulin 0.0625 0.3871 1
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0106 0.0583 0.6016
Loa Loa (eye worm) hypothetical protein 0.0121 0.0681 0.1206
Trichomonas vaginalis tubulin epsilon chain, putative 0.0471 0.2896 0.7481
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0024 0.0062 0.0062
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) beta-lactamase 0.0106 0.0583 0.1032
Brugia malayi MH2 domain containing protein 0.0017 0.0017 0.0044
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Trichomonas vaginalis tubulin gamma chain, putative 0.0161 0.0933 0.2409
Brugia malayi C2-HC type zinc finger protein C.e-MyT1 0.0053 0.0245 0.0634
Loa Loa (eye worm) hypothetical protein 0.0101 0.0554 0.098
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0024 0.0062 0.0072
Schistosoma mansoni scm-relatedprotein containing 4 mbt domains (sfmbt) 0.0046 0.0205 0.0238
Entamoeba histolytica tubulin alpha-1 chain 0.0471 0.2896 0.7473
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0022 0.005 0.0105
Loa Loa (eye worm) phosphatidylinositol 3 0.0046 0.0205 0.0363
Trichomonas vaginalis importin beta-1, putative 0.0069 0.0347 0.0896
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Echinococcus granulosus Tubulin alpha 1 chain 0.0471 0.2896 0.3371
Schistosoma mansoni alpha tubulin 0.0471 0.2896 0.3371
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.019 0.1118 0.2886
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein 0.0193 0.1136 0.2912
Trichomonas vaginalis D-aminoacylase, putative 0.0106 0.0583 0.1506
Trypanosoma cruzi myo-inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Brugia malayi Flap endonuclease-1 0.0028 0.0086 0.0221
Leishmania major beta tubulin 0.0625 0.3871 1
Echinococcus multilocularis sterol regulatory element binding protein 0.0042 0.0177 0.0177
Schistosoma mansoni ran 0.0062 0.0307 0.0357
Schistosoma mansoni ap endonuclease 0.0056 0.0269 0.0313
Schistosoma mansoni transcription factor LCR-F1 0.007 0.0353 0.0411
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0271 0.163 0.1897
Mycobacterium tuberculosis Probable lipase LipE 0.0106 0.0583 0.1272
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein 0.0363 0.221 0.5695
Plasmodium vivax SET domain protein, putative 0.0032 0.0114 0.0261
Schistosoma mansoni importin-beta 2 0.0016 0.0013 0.0015
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0046 0.0205 0.0498
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Entamoeba histolytica tubulin family protein 0.0625 0.3871 1
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Echinococcus granulosus mothers against decapentaplegic 5 0.0017 0.0017 0.002
Echinococcus granulosus beta tubulin 0.0625 0.3871 0.4506
Echinococcus multilocularis tubulin alpha 0.0351 0.2139 0.2139
Trichomonas vaginalis tubulin epsilon chain, putative 0.0625 0.3871 1
Trypanosoma brucei ULK family serine/threonine-protein kinase, putative 0.0016 0.0015 0.0013
Echinococcus granulosus L aminoadipate semialdehyde 0.0081 0.0425 0.0494
Schistosoma mansoni inositol monophosphatase 0.0038 0.0153 0.0178
Mycobacterium leprae conserved hypothetical protein 0.0106 0.0583 0.6016
Brugia malayi Nuclear hormone receptor family member nhr-31 0.002 0.0038 0.0099
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0062 0.0301 0.0533
Loa Loa (eye worm) nuclear hormone receptor family member nhr-41 0.002 0.0038 0.0068
Loa Loa (eye worm) mbt repeat family protein 0.0046 0.0205 0.0363
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0271 0.163 0.1897
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0087 0.0223
Schistosoma mansoni serine/threonine protein kinase 0.0092 0.0493 0.0573
Trypanosoma cruzi epsilon tubulin, putative 0.0384 0.2343 0.6042
Trichomonas vaginalis tubulin alpha chain, putative 0.0351 0.2139 0.5525
Echinococcus multilocularis beta tubulin 0.0625 0.3871 0.3871
Trichomonas vaginalis chromobox protein, putative 0.0041 0.017 0.0438
Loa Loa (eye worm) hypothetical protein 0.0042 0.0177 0.0313
Trypanosoma cruzi hypothetical protein, conserved 0.0106 0.0583 0.1485
Brugia malayi Nuclear hormone receptor family member nhr-49 0.002 0.0038 0.0099
Onchocerca volvulus 0.019 0.1118 0.7498
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Echinococcus granulosus tumor protein p63 0.0692 0.4301 0.5006
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) tubulin alpha-3 chain 0.0281 0.169 0.2991
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0046 0.0205 0.0506
Leishmania major importin beta-1 subunit, putative 0.0069 0.0347 0.0874
Toxoplasma gondii inositol(myo)-1(or 4)-monophosphatase 2, putative 0.0038 0.0153 0.0364
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.0056 0.0269 0.0477
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Trichomonas vaginalis tubulin epsilon chain, putative 0.0161 0.0933 0.2409
Trichomonas vaginalis chromobox protein, putative 0.0068 0.034 0.0878
Echinococcus multilocularis tar DNA binding protein 0.0062 0.0301 0.0301
Schistosoma mansoni thyroid hormone receptor 0.0145 0.083 0.0967
Echinococcus multilocularis inositol monophosphatase 1 0.0038 0.0153 0.0153
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Trichomonas vaginalis tubulin, putative 0.019 0.1118 0.2886
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0102 0.0263
Echinococcus granulosus peroxisome assembly protein 26 0.0471 0.2896 0.3371
Echinococcus multilocularis importin 5 0.0016 0.0013 0.0013
Schistosoma mansoni sex comb on midleg homolog 0.0046 0.0205 0.0238
Onchocerca volvulus 0.0043 0.0184 0.1233
Plasmodium falciparum alpha tubulin 2 0.0471 0.2896 0.7473
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Brugia malayi Latrophilin receptor protein 2 0.0096 0.0518 0.1338
Entamoeba histolytica hypothetical protein 0.0023 0.0056 0.0111
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.0179
Echinococcus multilocularis histone acetyltransferase MYST2 0.0053 0.0245 0.0245
Onchocerca volvulus 0.002 0.0038 0.0257
Loa Loa (eye worm) latrophilin receptor protein 2 0.0096 0.0518 0.0916
Brugia malayi latrophilin 2 splice variant baaae 0.0207 0.1222 0.3156
Brugia malayi Ligand-binding domain of nuclear hormone receptor family protein 0.002 0.0038 0.0099
Brugia malayi Nuclear hormone receptor family member nhr-25 0.002 0.0038 0.0099
Trichomonas vaginalis PIKK family atypical protein kinase 0.004 0.0162 0.0418
Brugia malayi Niemann-Pick C1 protein precursor 0.0098 0.053 0.1369
Leishmania major hypothetical protein, conserved 0.0106 0.0583 0.1485
Echinococcus multilocularis tubulin alpha 1C chain 0.0471 0.2896 0.2896
Trypanosoma brucei polo-like protein kinase 0.0092 0.0493 0.1251
Echinococcus multilocularis smad 0.0017 0.0017 0.0017
Mycobacterium ulcerans cell division protein FtsZ 0.0161 0.0933 1
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Echinococcus granulosus nuclear receptor 2DBD gamma 0.002 0.0038 0.0045
Loa Loa (eye worm) tubulin beta chain 0.0625 0.3871 0.6852
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) tubulin alpha-2 chain 0.0471 0.2896 0.5126
Leishmania major beta tubulin 0.0625 0.3871 1
Plasmodium falciparum importin beta, putative 0.0085 0.0449 0.113
Echinococcus granulosus inositol monophosphatase 1 0.0038 0.0153 0.0178
Echinococcus granulosus retinoic acid receptor rxr beta a 0.002 0.0038 0.0045
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.031 0.1874 0.4842
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Loa Loa (eye worm) transcription factor SMAD2 0.0245 0.1462 0.2588
Echinococcus granulosus Protein patched homolog 1 0.0042 0.0177 0.0206
Entamoeba histolytica tubulin alpha chain, putative 0.0471 0.2896 0.7473
Trichomonas vaginalis set domain proteins, putative 0.0249 0.149 0.385
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Wolbachia endosymbiont of Brugia malayi fructose-1,6-bisphosphatase 0.0038 0.0153 0.1111
Plasmodium vivax ataxin-2 like protein, putative 0.0053 0.0248 0.061
Mycobacterium tuberculosis Probable lipase LipD 0.0106 0.0583 0.1272
Trichomonas vaginalis hypothetical protein 0.0016 0.0013 0.0032
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Trichomonas vaginalis conserved hypothetical protein 0.0015 0.0003 0.0008
Trypanosoma brucei tubulin gamma chain 0.0384 0.2346 0.605
Schistosoma mansoni nuclear hormone receptor nor-1/nor-2 0.002 0.0038 0.0045
Trichomonas vaginalis tubulin beta chain, putative 0.019 0.1118 0.2886
Echinococcus multilocularis Tubulin alpha 1 chain 0.0471 0.2896 0.2896
Loa Loa (eye worm) hypothetical protein 0.0471 0.2896 0.5126
Loa Loa (eye worm) hypothetical protein 0.0096 0.0518 0.0916
Echinococcus granulosus tubulin epsilon chain 0.0384 0.2343 0.2727
Echinococcus granulosus GPCR family 2 0.0096 0.0518 0.0603
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Entamoeba histolytica hypothetical protein 0.0069 0.0347 0.0866
Treponema pallidum exodeoxyribonuclease (exoA) 0.0056 0.0269 0.2436
Echinococcus granulosus dnaJ subfamily B 0.0406 0.2482 0.2889
Schistosoma mansoni hypothetical protein 0.007 0.0353 0.0411
Loa Loa (eye worm) hypothetical protein 0.0081 0.0425 0.0752
Echinococcus granulosus suppression of tumorigenicity 18 protein 0.0053 0.0245 0.0286
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0106 0.0583 0.0679
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0271 0.163 0.1897
Leishmania major beta tubulin 0.0625 0.3871 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0271 0.163 0.163
Brugia malayi Nuclear hormone receptor-like 1 0.002 0.0038 0.0099
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein 0.0351 0.2139 0.5511
Brugia malayi nuclear receptor NHR-88 0.002 0.0038 0.0099
Echinococcus granulosus tubulin beta 4A class IVa 0.0625 0.3871 0.4506
Brugia malayi hypothetical protein 0.0121 0.0681 0.176
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Schistosoma mansoni hypothetical protein 0.0905 0.565 0.6576
Brugia malayi Tubulin alpha chain 0.0161 0.0933 0.2409
Trichomonas vaginalis conserved hypothetical protein 0.0038 0.0152 0.0391
Brugia malayi Calcitonin receptor-like protein seb-1 0.0302 0.1828 0.4723
Echinococcus granulosus alpha tubulin 0.0471 0.2896 0.3371
Schistosoma mansoni thyroid hormone receptor 0.0145 0.083 0.0967
Loa Loa (eye worm) tubulin alpha 2 0.031 0.1874 0.3318
Leishmania major beta tubulin 0.0625 0.3871 1
Leishmania major GTP-binding protein, putative 0.0062 0.0307 0.0769
Trichomonas vaginalis tubulin alpha chain, putative 0.019 0.1118 0.2886
Giardia lamblia GTOR 0.0046 0.0205 0.0315
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0092 0.0493 0.1251
Trichomonas vaginalis tubulin, putative 0.019 0.1118 0.2886
Schistosoma mansoni ap endonuclease 0.0056 0.0269 0.0313
Brugia malayi nuclear hormone receptor 0.002 0.0038 0.0099
Plasmodium falciparum ataxin-2 like protein, putative 0.0053 0.0248 0.061
Toxoplasma gondii exonuclease III APE 0.0056 0.0269 0.0665
Leishmania major myo-inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Echinococcus multilocularis FTZ F1 nuclear receptor protein 0.002 0.0038 0.0038
Onchocerca volvulus Protein ultraspiracle homolog 0.002 0.0038 0.0257
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0056 0.0269 0.0515
Brugia malayi ecdysteroid receptor 0.002 0.0038 0.0099
Echinococcus multilocularis chromobox protein 1 0.0068 0.034 0.034
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Trypanosoma brucei GTP-binding nuclear protein rtb2, putative 0.0062 0.0307 0.0769
Trichomonas vaginalis Importin beta-1 subunit, putative 0.0069 0.0347 0.0896
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Mycobacterium ulcerans lipase LipD 0.0106 0.0583 0.6016
Echinococcus granulosus FTZ F1 alpha 0.002 0.0038 0.0045
Schistosoma mansoni nuclear hormone receptor 0.002 0.0038 0.0045
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0106 0.0583 0.1507
Echinococcus granulosus tubulin alpha 0.0351 0.2139 0.249
Echinococcus multilocularis Tubulin alpha 1 chain 0.0471 0.2896 0.2896
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0096 0.0518 0.0603
Brugia malayi hypothetical protein 0.0034 0.0129 0.0332
Loa Loa (eye worm) nuclear Hormone Receptor family member 0.002 0.0038 0.0068
Mycobacterium leprae Probable lipase LipE 0.0106 0.0583 0.6016
Onchocerca volvulus 0.0028 0.0092 0.0615
Plasmodium vivax flap endonuclease 1, putative 0.0028 0.0086 0.0189
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Entamoeba histolytica Ran family GTPase 0.0062 0.0307 0.0762
Mycobacterium tuberculosis Cell division protein FtsZ 0.0161 0.0933 0.2114
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Toxoplasma gondii GTP-binding nuclear protein ran/tc4 0.0062 0.0307 0.0762
Schistosoma mansoni aminoadipate-semialdehyde dehydrogenase 0.0081 0.0425 0.0494
Loa Loa (eye worm) nuclear hormone receptor family member nhr-49 0.002 0.0038 0.0068
Onchocerca volvulus 0.0106 0.0583 0.3913
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0046 0.0205 0.0239
Schistosoma mansoni histone-lysine n-methyltransferase suv9 0.0043 0.0184 0.0214
Trichomonas vaginalis tubulin gamma chain, putative 0.0384 0.2343 0.6052
Trichomonas vaginalis CAMK family protein kinase 0.0045 0.0199 0.0513
Brugia malayi Nuclear hormone receptor family member nhr-41 0.002 0.0038 0.0099
Schistosoma mansoni tubulin subunit alpha 0.0471 0.2896 0.3371
Brugia malayi exodeoxyribonuclease III family protein 0.0056 0.0269 0.0695
Loa Loa (eye worm) nucleolar RNA-associated protein alpha 0.0905 0.565 1
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Mycobacterium tuberculosis Probable hydrolase 0.0106 0.0583 0.1272
Echinococcus multilocularis beta tubulin 0.0625 0.3871 0.3871
Trypanosoma cruzi zeta tubulin, putative 0.0498 0.3068 0.7921
Mycobacterium ulcerans esterase/lipase LipP 0.0106 0.0583 0.6016
Trypanosoma cruzi beta tubulin, putative 0.0625 0.3871 1
Schistosoma mansoni tubulin subunit alpha 0.0161 0.0933 0.1086
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0056 0.0269 0.2436
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) nuclear hormone receptor family member nhr-40 0.002 0.0038 0.0068
Echinococcus granulosus Tubulin alpha 1 chain 0.0471 0.2896 0.3371
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Echinococcus granulosus tubulin alpha 1C chain 0.0471 0.2896 0.3371
Mycobacterium tuberculosis Inositol-1-monophosphatase SuhB 0.0034 0.0128 0.0174
Onchocerca volvulus 0.0081 0.0425 0.285
Loa Loa (eye worm) hypothetical protein 0.003 0.01 0.0176
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0019 0.0033 0.0061
Echinococcus multilocularis Smad4 0.0017 0.0017 0.0017
Trypanosoma brucei importin beta-1 subunit, putative 0.0085 0.0449 0.1137
Entamoeba histolytica exodeoxyribonuclease III, putative 0.0056 0.0269 0.0665
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.0037 0.0145 0.0351
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Leishmania major flap endonuclease-1 (FEN-1), putative 0.0028 0.0086 0.0197
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0046 0.0205 0.0498
Echinococcus multilocularis ecdysone induced protein 78C 0.002 0.0038 0.0038
Giardia lamblia Alpha-tubulin 0.0471 0.2896 0.7424
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Schistosoma mansoni ran 0.0062 0.0307 0.0357
Echinococcus granulosus tubulin alpha 3 chain 0.0471 0.2896 0.3371
Echinococcus granulosus beta tubulin 0.0625 0.3871 0.4506
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Trichomonas vaginalis tubulin alpha chain, putative 0.0625 0.3871 1
Echinococcus multilocularis snurportin 1 0.0905 0.565 0.565
Loa Loa (eye worm) tubulin beta chain 0.0161 0.0933 0.1651
Schistosoma mansoni TGF-beta signal transducer Smad2 0.0017 0.0017 0.002
Toxoplasma gondii histone lysine methyltransferase SET1 0.0055 0.026 0.0642
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Trypanosoma cruzi polo-like protein kinase, putative 0.0092 0.0493 0.1251
Trichomonas vaginalis PIKK family atypical protein kinase 0.0027 0.0085 0.0219
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Toxoplasma gondii beta-1 tubulin, putative 0.0625 0.3871 1
Loa Loa (eye worm) importin-beta domain-containing protein 0.0016 0.0013 0.0023
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Echinococcus granulosus polycomb protein SCMH1 0.0046 0.0205 0.0238
Loa Loa (eye worm) tubulin alpha 2 0.031 0.1874 0.3318
Loa Loa (eye worm) kap beta 3 protein 0.0016 0.0013 0.0023
Loa Loa (eye worm) inositol-1 0.0038 0.0153 0.0271
Trichomonas vaginalis conserved hypothetical protein 0.0161 0.0933 0.2409
Trypanosoma brucei zeta tubulin, putative 0.0498 0.3068 0.7921
Schistosoma mansoni hypothetical protein 0.0207 0.1222 0.1422
Echinococcus granulosus COUP TF:Svp nuclear hormone receptor 0.002 0.0038 0.0045
Leishmania major zeta tubulin, putative 0.0498 0.3068 0.7921
Toxoplasma gondii beta tubulin 0.0625 0.3871 1
Brugia malayi Nuclear hormone receptor family member nhr-25 0.002 0.0038 0.0099
Onchocerca volvulus Polycomb protein Sfmbt homolog 0.0046 0.0205 0.1374
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0016 0.001 0.0011
Trichomonas vaginalis conserved hypothetical protein 0.0027 0.0081 0.0209
Trichomonas vaginalis penicillin-binding protein, putative 0.0106 0.0583 0.1506
Mycobacterium ulcerans hypothetical protein 0.0106 0.0583 0.6016
Trichomonas vaginalis PIKK family atypical protein kinase 0.0046 0.0205 0.0529
Echinococcus granulosus snurportin 1 0.0905 0.565 0.6576
Echinococcus multilocularis expressed conserved protein 0.0092 0.0492 0.0492
Toxoplasma gondii target of rapamycin (TOR), putative 0.0034 0.013 0.0303
Echinococcus multilocularis protein patched 0.0042 0.0177 0.0177
Mycobacterium tuberculosis Probable esterase/lipase LipP 0.0106 0.0583 0.1272
Leishmania major beta tubulin 0.0625 0.3871 1
Mycobacterium leprae cell division protein FtsZ 0.0161 0.0933 1
Onchocerca volvulus Bile acid receptor homolog 0.002 0.0038 0.0257
Loa Loa (eye worm) Smad1 0.0017 0.0017 0.003
Trypanosoma cruzi GTP-binding nuclear protein rtb2, putative 0.0062 0.0307 0.0769
Schistosoma mansoni patched 1 0.0042 0.0177 0.0206
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.007 0.0353 0.0353
Loa Loa (eye worm) hypothetical protein 0.0302 0.1828 0.3236
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Schistosoma mansoni inositol monophosphatase 0.0038 0.0153 0.0178
Echinococcus granulosus tubulin gamma 1 chain 0.0384 0.2346 0.2731
Trichomonas vaginalis conserved hypothetical protein 0.0161 0.0933 0.2409
Trypanosoma brucei flap endonuclease-1 (FEN-1), putative 0.0028 0.0086 0.0197
Echinococcus multilocularis Tubulin alpha 1 chain 0.0471 0.2896 0.2896
Loa Loa (eye worm) tubulin alpha 2 0.0119 0.0668 0.1183
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.0056 0.0269 0.0313
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0106 0.0583 0.0679
Brugia malayi Tubulin alpha-2 chain 0.0471 0.2896 0.7481
Brugia malayi Heterochromatin protein 1 0.0068 0.034 0.0878
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Echinococcus granulosus Nuclear hormone receptor family member nhr 41 0.002 0.0038 0.0045
Trichomonas vaginalis chromobox protein, putative 0.0041 0.017 0.0438
Plasmodium falciparum ataxin-2 like protein, putative 0.0053 0.0248 0.061
Brugia malayi tubulin alpha-2 chain 0.0471 0.2896 0.7481
Trypanosoma brucei alpha tubulin, putative 0.019 0.1118 0.2869
Toxoplasma gondii tubulin, putative 0.0032 0.0115 0.0265
Echinococcus granulosus Smad4 0.0017 0.0017 0.002
Giardia lamblia GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0584
Brugia malayi Inositol-1 0.0038 0.0153 0.0395
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.0032 0.0114 0.0132
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Leishmania major beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis tubulin gamma chain, putative 0.0625 0.3871 1
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Plasmodium falciparum GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0762
Echinococcus granulosus Niemann Pick C1 protein 0.0098 0.053 0.0617
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Trichomonas vaginalis Importin beta-1 subunit, putative 0.0069 0.0347 0.0896
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.0056 0.0269 0.0485
Schistosoma mansoni Tr4/Tr2 (homologue) 0.002 0.0038 0.0045
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Leishmania major beta tubulin 0.0625 0.3871 1
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Loa Loa (eye worm) beta-tubulin 0.0625 0.3871 0.6852
Entamoeba histolytica Flap nuclease, putative 0.0028 0.0086 0.0189
Echinococcus granulosus tubulin subunit beta 0.0625 0.3871 0.4506
Mycobacterium tuberculosis Conserved protein 0.0106 0.0583 0.1272
Mycobacterium tuberculosis Conserved protein 0.0106 0.0583 0.1272
Brugia malayi hypothetical protein 0.007 0.0353 0.0912
Schistosoma mansoni tubulin subunit delta 0.0161 0.0933 0.1086
Brugia malayi Tubulin beta-1 chain 0.0625 0.3871 1
Loa Loa (eye worm) hypothetical protein 0.0032 0.0114 0.0201
Echinococcus granulosus smad 0.0017 0.0017 0.002
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0096 0.0518 0.1338
Echinococcus multilocularis GTP binding nuclear protein Ran 0.0062 0.0307 0.0307
Loa Loa (eye worm) steroid hormone receptor 0.002 0.0038 0.0068
Plasmodium vivax holo-[acyl-carrier-protein] synthase, putative 0.0023 0.0056 0.0111
Echinococcus granulosus sterol regulatory element binding protein 0.0042 0.0177 0.0206
Trypanosoma brucei hypothetical protein, conserved 0.0023 0.0056 0.0119
Echinococcus granulosus ecdysone induced protein 78C 0.002 0.0038 0.0045
Trichomonas vaginalis tubulin alpha chain, putative 0.019 0.1118 0.2886
Brugia malayi steroid hormone receptor 0.002 0.0038 0.0099
Schistosoma mansoni flap endonuclease-1 0.0025 0.0069 0.008
Echinococcus granulosus 5'partial|histone lysine N methyltransferase SETDB2 0.003 0.0102 0.0119
Trypanosoma cruzi PAB1-binding protein , putative 0.0053 0.0248 0.0617
Echinococcus multilocularis cpg binding protein 0.003 0.0102 0.0102
Plasmodium falciparum holo-[acyl-carrier-protein] synthase, putative 0.0023 0.0056 0.0111
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Trypanosoma brucei PAB1-binding protein , putative 0.0053 0.0248 0.0617
Trypanosoma brucei inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Entamoeba histolytica serine/threonine protein kinase, putative 0.0092 0.0493 0.1244
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Trichomonas vaginalis PIKK family atypical protein kinase 0.0027 0.0085 0.0219
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Brugia malayi Nuclear hormone receptor family member nhr-1 0.002 0.0038 0.0099
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Loa Loa (eye worm) tubulin beta-1 chain 0.0625 0.3871 0.6852
Echinococcus granulosus chromobox protein 1 0.0068 0.034 0.0396
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0046 0.0205 0.0506
Echinococcus granulosus transportin 1 0.0016 0.0013 0.0015
Toxoplasma gondii 4'-phosphopantetheinyl transferase superfamily protein 0.0023 0.0056 0.0111
Brugia malayi Tubulin gamma chain 0.0384 0.2346 0.606
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0018 0.0022 0.0057
Toxoplasma gondii alpha-tubulin I, putative 0.0471 0.2896 0.7473
Echinococcus multilocularis tubulin epsilon chain 0.0384 0.2343 0.2343
Trichomonas vaginalis D-aminoacylase, putative 0.0106 0.0583 0.1506
Loa Loa (eye worm) MBCTL1 0.0053 0.0245 0.0434
Treponema pallidum cell division protein FtsZ 0.0161 0.0933 1
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Echinococcus multilocularis tubulin alpha 3 chain 0.0471 0.2896 0.2896
Trypanosoma cruzi polo-like protein kinase, putative 0.0092 0.0493 0.1251
Echinococcus multilocularis chromobox protein 1 0.0068 0.034 0.034
Trichomonas vaginalis tubulin beta chain, putative 0.0625 0.3871 1
Trichomonas vaginalis D-aminoacylase, putative 0.0106 0.0583 0.1506
Echinococcus multilocularis neuropeptide receptor A26 0.047 0.2892 0.2892
Onchocerca volvulus Serine\/threonine kinase homolog 0.0092 0.0493 0.3305
Brugia malayi aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 0.0081 0.0425 0.1097
Trichomonas vaginalis chromobox protein, putative 0.0068 0.034 0.0878
Toxoplasma gondii 4'-phosphopantetheinyl transferase domain-containing protein 0.0023 0.0056 0.0111
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0096 0.0518 0.0518
Trichomonas vaginalis tubulin alpha chain, putative 0.019 0.1118 0.2886
Schistosoma mansoni tubulin subunit alpha 0.0471 0.2896 0.3371
Giardia lamblia Delta tubulin 0.0161 0.0933 0.2238
Plasmodium vivax tubulin gamma chain, putative 0.0384 0.2346 0.6047
Loa Loa (eye worm) hypothetical protein 0.0051 0.0236 0.0419
Trichomonas vaginalis ap endonuclease, putative 0.0056 0.0269 0.0695
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0543
Echinococcus granulosus hepatocyte nuclear factor 4 alpha 0.002 0.0038 0.0045
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0046 0.0205 0.0239
Echinococcus granulosus chromobox protein 1 0.0068 0.034 0.0396
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Echinococcus multilocularis importin subunit beta 1 0.0085 0.0449 0.0449
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0087 0.0223
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0092 0.0493 0.0872
Trypanosoma cruzi GTP-binding nuclear protein rtb2, putative 0.0062 0.0307 0.0769
Schistosoma mansoni sex comb on midleg homolog 0.0046 0.0205 0.0238
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0015 0.0003 0.0008
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0037 0.0145 0.0351
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.0056 0.0269 0.0269
Plasmodium vivax tubulin epsilon chain, putative 0.0384 0.2343 0.6039
Leishmania major beta tubulin 0.0625 0.3871 1
Plasmodium vivax delta tubulin, putative 0.0161 0.0933 0.2384
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0056 0.0269 0.2436
Schistosoma mansoni tubulin subunit alpha 0.0471 0.2896 0.3371
Echinococcus multilocularis peroxisome assembly protein 26 0.0471 0.2896 0.2896
Echinococcus multilocularis nuclear receptor 2DBD gamma 0.002 0.0038 0.0038
Onchocerca volvulus Heterochromatin protein 1 homolog 0.0041 0.017 0.114
Loa Loa (eye worm) BEN-1 protein 0.0625 0.3871 0.6852
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Schistosoma mansoni niemann-pick C1 (NPC1) 0.0099 0.054 0.0628
Schistosoma mansoni retinoic acid receptor RXR 0.002 0.0038 0.0045
Brugia malayi RNA recognition motif domain containing protein 0.0062 0.0301 0.0778
Mycobacterium tuberculosis Possible conserved lipoprotein LpqK 0.0106 0.0583 0.1272
Brugia malayi Tubulin beta chain 0.0161 0.0933 0.2409
Trichomonas vaginalis esterase, putative 0.0106 0.0583 0.1506
Leishmania major beta tubulin 0.0625 0.3871 1
Echinococcus multilocularis histone lysine N methyltransferase SETMAR 0.0032 0.0114 0.0114
Entamoeba histolytica myo-inositol monophosphatase, putative 0.0038 0.0153 0.0364

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Targets
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 25450  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 22205  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 27459  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 26961  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 22252  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23996  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23078  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 20827  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28024  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28324  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 25450  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22205  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 27459  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 26961  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22252  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23996  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23078  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 20827  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28024  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28324  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 25450  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22205  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 27459  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 26961  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22252  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23996  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23078  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 20827  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28024  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28324  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclea